Ameritas Investment Partners’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
Ameritas Investment Partners's ASTH Position: Q2 2026 in Review
Ameritas Investment Partners increased its Astrana Health (ASTH) stake by 21% in Q2 2026, buying an estimated $26.3K and bringing the position to 4,141 shares worth $192K. The position accounts for 0.01% of the portfolio, ranked #1412.
Ameritas Investment Partners first reported a position in ASTH in Q2 2018 and has held it in 33 quarters since. The position peaked at $268K in Q3 2021. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Ameritas Investment Partners held 4,141 shares of Astrana Health worth $192K as of Q2 2026.
- Ameritas Investment Partners bought 732 Astrana Health shares in Q2 2026, an estimated $26.3K.
- Astrana Health made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1412 holding.
- Ameritas Investment Partners first reported a position in Astrana Health in Q2 2018 and has held it in 33 quarters since.
- Ameritas Investment Partners's Astrana Health position peaked at $268K in Q3 2021.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.